We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14B
AUM Growth
+$1.55B
(+12%)
Cap. Flow
+$55.8M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
266
New
32
Increased
101
Reduced
90
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$114M |
| 2 |
Novartis
NVS
|
+$98.3M |
| 3 |
Carter's
CRI
|
+$80.1M |
| 4 |
Brixmor Property Group
BRX
|
+$77.5M |
| 5 |
Citigroup
C
|
+$75.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDCO
Medicines Co
MDCO
|
+$340M |
| 2 |
Adobe
ADBE
|
+$106M |
| 3 |
Marriott International
MAR
|
+$99.8M |
| 4 |
Cisco
CSCO
|
+$81.3M |
| 5 |
Progressive
PGR
|
+$62.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.58% |
| 2 | Healthcare | 17.58% |
| 3 | Industrials | 13.74% |
| 4 | Financials | 11.64% |
| 5 | Consumer Discretionary | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dollar Tree
DLTR
$24.8B
| $13.9M | 0.1% |
+148,303
| New | +$15.6M |
|
|
MNTA
177
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $13.9M | 0.1% |
703,653
-279,563
| -28% | -$4.47M |
|
178
Fate Therapeutics
FATE
$288M
| $13.8M | 0.1% |
704,843
-200,776
| -22% | -$3.19M |
|
179
JPMorgan Chase
JPM
$948B
| $13.6M | 0.1% |
97,380
+33,370
| +52% | +$4.28M |
|
180
Grocery Outlet
GO
$974M
| $13.5M | 0.1% |
414,960
+340,609
| +458% | +$11M |
|
181
Avery Dennison
AVY
$13.1B
| $12.7M | 0.09% |
96,905
-290
| -0.3% | -$36.6K |
|
|
APLS
182
DELISTED
Apellis Pharmaceuticals
APLS
| $12.1M | 0.09% |
395,490
+101,589
| +35% | +$2.81M |
|
183
Abbott
ABT
$186B
| $11.3M | 0.08% |
129,988
-474
| -0.4% | -$39.7K |
|
184
Repay Holdings
RPAY
$328M
| $11M | 0.08% |
749,283
+15,069
| +2% | +$210K |
|
185
FirstService
FSV
$6.26B
| $10.5M | 0.08% |
+113,195
| New | +$10.7M |
|
|
ORTX
186
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $10.5M | 0.07% |
76,195
-31,516
| -29% | -$3.83M |
|
187
Matsons
MATX
$6.21B
| $10M | 0.07% |
245,717
-99,161
| -29% | -$3.78M |
|
188
Texas Instruments
TXN
$256B
| $9.18M | 0.07% |
71,555
-130
| -0.2% | -$16K |
|
189
Merck
MRK
$317B
| $8.82M | 0.06% |
101,608
-346
| -0.3% | -$28.4K |
|
190
Target
TGT
$66.8B
| $8.58M | 0.06% |
66,945
-250
| -0.4% | -$29.3K |
|
191
Coca-Cola
KO
$372B
| $8.25M | 0.06% |
148,980
-440
| -0.3% | -$23.7K |
|
192
Verizon
VZ
$194B
| $8.15M | 0.06% |
132,755
-580
| -0.4% | -$35K |
|
193
Vail Resorts
MTN
$5.28B
| $8.05M | 0.06% |
33,580
-61
| -0.2% | -$14.4K |
|
194
CVS Health
CVS
$124B
| $7.99M | 0.06% |
107,550
-330
| -0.3% | -$23.2K |
|
195
NextEra Energy
NEE
$176B
| $7.29M | 0.05% |
120,420
-352
| -0.3% | -$20.6K |
|
196
Archer Daniels Midland
ADM
$37.3B
| $6.99M | 0.05% |
150,730
-459
| -0.3% | -$19.6K |
|
197
Jack Henry & Associates
JKHY
$11.1B
| $6.84M | 0.05% |
46,989
-230
| -0.5% | -$33.6K |
|
|
FITB
198
Fifth Third Bancorp
FITB
$51.7B
| $6.49M | 0.05% |
211,095
-775
| -0.4% | -$22.7K |
|
|
199
Progressive
PGR
$125B
| $6.2M | 0.04% |
85,706
-869,131
| -91% | -$62.7M |
|
200
Alphabet (Google) Class C
GOOG
$4.36T
| $5.54M | 0.04% |
82,820
-216,560
| -72% | -$14M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Westfield Capital Management held 266 positions worth $14B, up 12% from $12.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Westfield Capital Management's Q4 2019 filing shows 32 new, 101 increased, 90 reduced and 35 closed positions. Its largest new stake was Novartis: 1,095,518 shares worth $104M. The largest sale was Medicines Co, an estimated $340M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q4 2019 buy was Novartis: 1,095,518 shares worth $104M.
- Westfield Capital Management added most to TransDigm Group in Q4 2019, an estimated $114M increase.
- Westfield Capital Management's biggest Q4 2019 reduction was Medicines Co, cutting an estimated $340M.
- Westfield Capital Management fully exited Adobe in Q4 2019, selling an estimated $106M.
- Westfield Capital Management's ten largest holdings make up 20% of its $14B portfolio in Q4 2019.
- Westfield Capital Management opened 32 new positions and closed 35 in Q4 2019.
- Westfield Capital Management's portfolio value rose 12% quarter-over-quarter to $14B.
Based on Westfield Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.